Total Payments
$10,566
2024 Payments
$1,040
Companies
46
Transactions
715
Medicare Patients
1,810
Medicare Billing
$152,821
Payment Breakdown by Category
Food & Beverage$10,513 (99.5%)
Education$53.03 (0.5%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,513 | 706 | 99.5% |
| Education | $53.03 | 9 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,345 | 67 | $0 (2024) |
| Novo Nordisk Inc | $1,006 | 76 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $807.07 | 49 | $0 (2024) |
| ABBVIE INC. | $792.55 | 47 | $0 (2024) |
| Lilly USA, LLC | $711.41 | 60 | $0 (2024) |
| PFIZER INC. | $530.49 | 45 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $502.29 | 40 | $0 (2022) |
| SANOFI-AVENTIS U.S. LLC | $455.11 | 31 | $0 (2020) |
| Merck Sharp & Dohme LLC | $450.46 | 38 | $0 (2022) |
| Amgen Inc. | $412.90 | 25 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,040 | 54 | AstraZeneca Pharmaceuticals LP ($256.73) |
| 2023 | $867.84 | 51 | AbbVie Inc. ($182.97) |
| 2022 | $1,271 | 77 | ABBVIE INC. ($219.85) |
| 2021 | $1,675 | 105 | Novo Nordisk Inc ($215.96) |
| 2020 | $828.85 | 55 | AstraZeneca Pharmaceuticals LP ($132.90) |
| 2019 | $1,582 | 126 | AstraZeneca Pharmaceuticals LP ($235.20) |
| 2018 | $1,744 | 126 | AstraZeneca Pharmaceuticals LP ($266.04) |
| 2017 | $1,558 | 121 | SANOFI-AVENTIS U.S. LLC ($234.30) |
All Payment Transactions
715 individual payment records from CMS Open Payments — Page 1 of 29
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $16.45 | General |
| Category: ANTIBIOTIC | ||||||
| 11/26/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $15.25 | General |
| Category: Respiratory | ||||||
| 10/23/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.64 | General |
| Category: Obesity | ||||||
| 10/10/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $21.17 | General |
| Category: Respiratory | ||||||
| 10/08/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.90 | General |
| Category: DIABETES | ||||||
| 09/17/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $13.74 | General |
| Category: VACCINES | ||||||
| 09/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: NEUROSCIENCE | ||||||
| 08/29/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $18.22 | General |
| Category: Respiratory | ||||||
| 08/15/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $15.98 | General |
| Category: PSYCHIATRY | ||||||
| 08/13/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $26.49 | General |
| Category: Inflammation | ||||||
| 08/06/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: Diabetes | ||||||
| 07/30/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $20.91 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 07/23/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.71 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/18/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.94 | General |
| Category: DIABETES | ||||||
| 07/11/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.84 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/10/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.45 | General |
| Category: Diabetes | ||||||
| 06/25/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.09 | General |
| Category: Cardio-renal | ||||||
| 06/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $31.25 | General |
| Category: NEUROSCIENCE | ||||||
| 06/04/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $22.65 | General |
| Category: Inflammation | ||||||
| 05/30/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.86 | General |
| Category: Respiratory | ||||||
| 05/24/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: Insomnia | ||||||
| 05/16/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $17.46 | General |
| Category: Diabetes | ||||||
| 05/14/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $18.30 | General |
| Category: Respiratory | ||||||
| 04/30/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.39 | General |
| Category: Respiratory | ||||||
| 04/29/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $21.19 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 374 | 658 | $94,379 | $36,316 |
| 2022 | 11 | 419 | 708 | $94,124 | $36,005 |
| 2021 | 10 | 479 | 792 | $107,658 | $43,822 |
| 2020 | 12 | 538 | 915 | $104,644 | $36,677 |
Total Patients
1,810
Total Services
3,073
Medicare Billing
$152,821
Procedure Codes
42
All Medicare Procedures & Services
42 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 121 | 253 | $52,371 | $19,096 | 36.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 109 | 193 | $26,248 | $10,601 | 40.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 37 | 37 | $7,918 | $4,602 | 58.1% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 29 | 58 | $2,494 | $544.49 | 21.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 18 | 18 | $715.50 | $528.48 | 73.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 14 | 44 | $2,332 | $432.55 | 18.5% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 17 | 17 | $561.00 | $350.40 | 62.5% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2023 | 11 | 15 | $1,095 | $110.46 | 10.1% |
| 81003 | Automated urinalysis test | Office | 2023 | 18 | 23 | $644.00 | $50.60 | 7.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 123 | 248 | $50,344 | $18,623 | 37.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 105 | 194 | $25,802 | $9,592 | 37.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 37 | 37 | $7,770 | $4,646 | 59.8% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 14 | 14 | $924.00 | $905.52 | 98.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 25 | 25 | $975.00 | $698.75 | 71.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 23 | 68 | $3,536 | $547.20 | 15.5% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 32 | 54 | $2,268 | $517.24 | 22.8% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2022 | 16 | 16 | $512.00 | $337.44 | 65.9% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2022 | 15 | 18 | $1,296 | $83.88 | 6.5% |
| 81003 | Automated urinalysis test | Office | 2022 | 17 | 21 | $567.00 | $46.71 | 8.2% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 12 | 13 | $130.00 | $8.25 | 6.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 140 | 280 | $56,280 | $22,025 | 39.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 120 | 212 | $27,984 | $11,266 | 40.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 37 | 37 | $7,696 | $4,760 | 61.9% |
| 99496 | Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge | Office | 2021 | 15 | 15 | $5,955 | $3,241 | 54.4% |
| 90686 | Vaccine for influenza for administration into muscle, 0.5 ml dosage, quadrivalent, preservation free | Office | 2021 | 41 | 41 | $1,312 | $841.73 | 64.2% |
About Dr. Chad Blunt, M.D
Dr. Chad Blunt, M.D is a Family Medicine healthcare provider based in Oak Harbor, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1447345301.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Chad Blunt, M.D has received a total of $10,566 in payments from pharmaceutical and medical device companies, with $1,040 received in 2024. These payments were reported across 715 transactions from 46 companies. The most common payment nature is "Food and Beverage" ($10,513).
As a Medicare-enrolled provider, Blunt has provided services to 1,810 Medicare beneficiaries, totaling 3,073 services with total Medicare billing of $152,821. Data is available for 4 years (2020–2023), covering 42 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Oak Harbor, OH
- Active Since 10/04/2006
- Last Updated 10/06/2020
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1447345301
Products in Payments
- JARDIANCE (Drug) $742.12
- FARXIGA (Drug) $573.00
- Ozempic (Drug) $475.00
- VRAYLAR (Drug) $421.09
- JANUVIA (Drug) $374.96
- ELIQUIS (Drug) $330.47
- ENTRESTO (Drug) $323.32
- XARELTO (Drug) $317.10
- BREZTRI (Drug) $288.53
- UBRELVY (Drug) $285.74
- CHANTIX (Drug) $284.22
- XIFAXAN (Drug) $276.20
- TOUJEO (Drug) $260.06
- NURTEC ODT (Drug) $235.90
- EMGALITY (Drug) $231.14
- Otezla (Drug) $225.78
- SYMBICORT (Drug) $210.19
- Kerendia (Drug) $203.87
- TRULICITY (Drug) $196.64
- INVOKANA (Drug) $179.17
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Oak Harbor
Sean Callahan, M.d, M.D
Family Medicine — Payments: $10,162
Family Medicine $10,162
Mr. Robert Lycksell, Md, MD
Family Medicine — Payments: $4,867
Family Medicine $4,867
Douglas Langrock, Md, MD
Family Medicine — Payments: $4,059
Family Medicine $4,059
Dr. Krishna Ragothaman, Md, MD
Family Medicine — Payments: $3,902
Family Medicine $3,902
David Lemme, D.o., M.p.h, D.O., M.P.H
Family Medicine — Payments: $548.65
Family Medicine $548.65
Janette Reeves, D.o, D.O
Family Medicine — Payments: $539.62
Family Medicine $539.62